New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Tired skin and fine lines don’t always require ...

OpenAI created a lot of hype around hardware last year after it acquired former Apple design head Jony Ive’s startup io. While the company is tight-lipped about the upcoming product, OpenAI Chief ...

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...

There's a new development in the yearslong international mystery over Havana Syndrome: The U.S. has obtained and has been testing a device that officials believe could be linked to the debilitating ...

The U.S. government quietly acquired a device in late 2024 that officials believe may be connected to the debilitating condition known as Havana Syndrome, which more than 1,500 American officials have ...

The Diamondbacks missed out on Alex Bregman and pivoted to another accomplished veteran. Arizona acquired eight-time All-Star Nolan Arenado for pitching prospect Jack Martinez, the Cardinals announced ...

As the New Year sets in, you might feel the urge to recalibrate—that familiar January moment, when people resolve to drink more water, swear off carbs, adjust their Ozempic dosage, or panic-book their ...

Ten years ago U.S. officials stationed in Cuba started reporting a strange collection of symptoms, from ringing ears and dizziness to crushing headaches and memory loss. The symptoms, collectively ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Shrishty is a decade-old journalist covering a variety of beats between politics to pop culture, but movies are her first love, which led her to study Film and TV Development at UCLAx. She lives and ...

The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...